期刊文献+

不同粘度对比剂对冠状动脉造影患者肾功能的影响 被引量:4

Comparison of Different Viscosity Agent Effect on Renal Functions of Patients Undergoing Coronary Angiography
原文传递
导出
摘要 目的:对比剂肾病(CIN)是介入治疗中常见并发症之一。由于对比剂肾病发病机制复杂,其确切的机制尚不明确,有研究认为应用渗透压相似的对比剂,高粘度组对比剂引起CIN的几率明显高于低粘度组。本研究探讨接受不同粘度对比剂冠状动脉造影检查的患者术后引起肾功能损害的差异及其可能的机制。方法:80例接受冠状动脉造影检查的患者随机分为两组,分别为20℃碘海醇组、37℃碘海醇组,每组各40例。分别于冠脉造影前8h、冠脉造影后48 h采集同一患者肘正中静脉血进行血清肌酐(Scr)、血清胱抑素C(CysC)检测,并对数据进行统计学分析。结果:两组患者组间比较基本资料无明显差异,两组患者术后Scr、CysC较术前均升高,差异均有统计学意义(P<0.05);20℃碘海醇组术后Scr较37℃碘海醇组升高不明显,差异无统计学意义(P>0.05);20℃碘海醇组术后CysC较37℃碘海醇组升高明显,差异有统计学意义(P<0.05)。结论:冠脉造影检查时,对比剂对患者的肾功能有损害;选择低粘度对比剂可能减少其对冠状动脉造影患者的肾功能的不良影响;其作用机制可能与对比剂改变血液粘滞性,从而影响肾血流有关。 Objective: Contrast agent nephropathy (CIN) is one of common complications in interventional therapy. Due to the complexity of contrast medium kidney disease pathogenesis, the exact mechanism is unclear, a study that application of osmotic pressure similar to those of contrast medium and high viscosity group contrast medium caused CIN group significantly higher than the risk of low viscosity. Methods: 80 cases underwent coronary artery angiography were randomly divided into two groups 20 ℃ iohexol group and 37 ℃ iohexol group, 40 patients in each group. Before coronary angiography respectively 8 h, 48 h after coronary angiography to collect elbow in the middle of venous blood serum creatinine (Scr), serum (chalone C (CysC) and the data statistical analysis. Results: Two groups of patients with no difference between the basic data is compared between groups. Two groups of patients with postoperative Scr, CysC is tied to elevated preoperative, difference have statistical significance (P 〈 0.05); 20 ℃ sea iodine, alcohol group of Scr is 37 ℃ after iodine higher alcohol group is not obvious, there was no statistically significant difference (P 〉 0.05); 20 ℃ sea iodine, alcohol alcohol CysC is 37 ℃ after iodine sea group increased significantly, the difference was statistically significant (P 〈 0.05), Conclusion: Coronary angiography examination, contrast material on renal function in patients with damage; Choose low viscosity contrast agent could reduce its right of renal function in patients with coronary angiography;the mechanism may be related to changes in blood viscosity contrast agent, thus affecting the renal blood flow associated.
出处 《现代生物医学进展》 CAS 2014年第2期275-277,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金青年科学基金项目(81200235)
关键词 对比剂 粘度 肾功能 Contrast Viscosity Renal function
  • 相关文献

参考文献15

  • 1Jabara IL Gadesam RR, Pendyala LK, et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention[J]. Am J Cardiol, 2009, 103(12): 1657-1662.
  • 2Aspelin P. Nephrotoxicity and the role of contrast media[J]. Radiation Med, 2004, 22(6): 377-378.
  • 3Seeliger E, Sendeski M, Rihal CS, et al. Contrast-induced kidney injury: mechanisms, risk factors, and prevention[J]. Eur Heart J, 2012, 33(16): 2007-2915.
  • 4Sharma SK, Iodinated contrast media and contrast-indnced nephropa- thy is there a ,prefened costeffective agent? [J]. J Invasive Cardiol,2008,20(5):245-248.
  • 5Sendeski M, Patzak A, Persson PB. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, mono- merle and dimeric agents[J]. Invest Radiol, 2010, 45(8): 453-457.
  • 6Briguori C. Selection of contrast media: current status of understanding[J]. G Ital Cardiol (Rome), 2009, 10(2): 79-87.
  • 7Thomsen HS. Europen Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media [J]. Eur J Radiol, 2006, 60(3): 307-313.
  • 8Gami AS, Garovic VD. Contrast nephropathy after coronary anography [J]. Mayo Clin Proe, 2004, 79(2): 211-219.
  • 9Villeval'de SV, Gudgalis NI, Kkobalava ZhD. Cistatin C as a novel marker of renal function impairement and cardiovascular risk [J]. Kardiologiia, 2010, 50(6): 78-82.
  • 10Briguori C, Visconti G, Rivera NV, et al. Cistatin C and contrast- induced acute kidney injury[J]. Circulation, 2010, 121 (19): 2117-21 22.

同被引文献37

  • 1慕朝伟,高润霖,陈纪林,杨跃进,乔树宾,姚民,秦学文,徐波,刘海波,吴永建,袁晋青,陈珏,李建军,戴军,尤士杰,窦克非,邱洪,王增武.非离子型碘造影剂的过敏样反应[J].中国循环杂志,2007,22(3):172-175. 被引量:45
  • 2周玉杰,霍勇,卢才义,等.心脏病介入治疗疑难问题-造影剂[M].北京:中国协和医科大学出版社,2006:43.
  • 3周杰,汪坤,李必龙,等.血清胱抑素C与脑利钠肽联合检测在对比剂肾病早期诊断中的临床意义[J].中国基层医药,2014,21(z1):1-3.
  • 4Lameire N, Van Biesen W, Vanholder R. Acute renal failure [J]. Lancet, 2005,365(57) :41 43.
  • 5Toprak O, Cirit M, Yesil M, et al . Impact of diabetic and prediabetic state on development of contrast induced nephrop- athy in patients with chronic kidney disease[J]. Nephrol Dial Transplant, 2006,22(3) :819-826.
  • 6Fox CS, Golden SH, Anderson C, et al . Update on preven- tion of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Dia- betes Association[J]. Diabetes Care, 2015 ~ 38(9) ~ 1777-1803,.
  • 7Mehran R. Contrast-induced nephropathy remains a serious complication of PCI[J]. J lnterv Cardiol, 2007,20 (3) : 236-240.
  • 8Kanei Y, Ratcliffe J, et al . The impact of iso-osmolar con- trast use in emergent percutaneous coronary intervention for ST segment elevation myocardial infarction [J]. J Invasive Cardiol, 2011,23(11) :448-450.
  • 9Meh ran R, Aymong ED, Nikolsky E, et al . A simple risk score for prediction of contrast-induced nephropathy after per- cutaneous coronary intervention: development and initial vali- dation[J]. J Azn Coll Cardiol, 2004,44 (7):1393-1399.
  • 10. Tumlin J, Stacul F, Adam A, et al . Pathophysiology of con- trast-induced nephropathy[J]. Am J Cardiol, 2006, 98(6A) 14K-20K.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部